Investing.com - StemRIM reported on Thursday fourth quarter earnings that beat analysts' forecasts and revenue that was inline with expectations.
StemRIM announced earnings per share of ¥-7.54 on revenue of ¥0.00. Analysts polled by Investing.com anticipated EPS of ¥-10 on revenue of ¥0.00.
StemRIM shares are up 27.81% from the beginning of the year , still down 0.27% from its 52 week high of ¥1,129.00 set on Friday, September 9, 2022. They are outperforming the EUR/USD which is down 0% year to date.
StemRIM follows other major Healthcare sector earnings this month
StemRIM's report follows an earnings matched by Asahi Intecc on Friday, August 12, 2022, who reported EPS of ¥11.53 on revenue of ¥21.06B, compared to forecasts EPS of ¥11.53 on revenue of ¥21.06B.
JEOL Ltd had beat expectations on Friday, August 12, 2022 with third quarter EPS of ¥63.03 on revenue of ¥28.86B, compared to forecast for EPS of ¥41.93 on revenue of ¥28.94B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar